FAST-Forward Trial Confirms 1-Week Breast RT at 10 Years Edited by Victoria Stern Lancet Oncol. 2026;27(6):686-698. doi:10.1016/S1470-2045(26)00076-8

https://www.medscape.com/viewarticle/fast-forward-trial-confirms-1-week-breast-rt-10-years-2026a1000lbd?src= At 10 years of follow-up, the landmark FAST-Forward trial confirmed that a 1-week radiotherapy regimen of 26 Gy in five fractions provided durable cancer control and similar long-term toxicity compared with the standard 3-week schedule in patients with early-stage breast cancer, supporting its continued use as a standard of care.